Next Article in Journal
Complex Reconstruction After Extreme Fournier’s Gangrene; A Case Report
Previous Article in Journal
Immunohistochemical Pattern—A Prognostic Factor for Synchronous Gastrointestinal Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMMS
Volume 7
Issue 2
10.22543/7674.72.P257260
jmms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Journal of Mind and Medical Sciences is published by MDPI from Volume 12 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Valparaiso University (ValpoScholar).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Unexpected Hope for a Multiple Myeloma Patient

by
Minodora Cezarina Onisâi
1,2,*,
Iuliana Iordan
1,
Mihaela Gaman
1,2,
Horia Bumbea
1,2 and
Ana-Maria Vlădăreanu
1,2
1
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2
Department of Hematology, Emergency University Hospital Bucharest, Splaiul Independentei, No. 169, 050098 Bucharest, Romania
*
Author to whom correspondence should be addressed.
J. Mind Med. Sci. 2020, 7(2), 257-260; https://doi.org/10.22543/7674.72.P257260
Submission received: 29 June 2020 / Revised: 14 August 2020 / Accepted: 14 August 2020 / Published: 29 September 2020

Abstract

Multiple myeloma (MM) is a plasma cell neoplasm, characterized by periods of remission and relapses. The emergence of novel therapies, with multiple mechanisms of action and fewer adverse reactions, brings more and better options and also a higher survival rate. However, MM is still an incurable disease, and patients eventually become refractory to an extensive range of therapies. We present the case of a patient diagnosed with MM standard risk, who was at first refractory to multiple treatment regimens, and then had an unexpected and stable complete response to a newer drug of the same class.
Keywords: multiple myeloma; refractory; proteasome inhibitors multiple myeloma; refractory; proteasome inhibitors

Share and Cite

MDPI and ACS Style

Onisâi, M.C.; Iordan, I.; Gaman, M.; Bumbea, H.; Vlădăreanu, A.-M. Unexpected Hope for a Multiple Myeloma Patient. J. Mind Med. Sci. 2020, 7, 257-260. https://doi.org/10.22543/7674.72.P257260

AMA Style

Onisâi MC, Iordan I, Gaman M, Bumbea H, Vlădăreanu A-M. Unexpected Hope for a Multiple Myeloma Patient. Journal of Mind and Medical Sciences. 2020; 7(2):257-260. https://doi.org/10.22543/7674.72.P257260

Chicago/Turabian Style

Onisâi, Minodora Cezarina, Iuliana Iordan, Mihaela Gaman, Horia Bumbea, and Ana-Maria Vlădăreanu. 2020. "Unexpected Hope for a Multiple Myeloma Patient" Journal of Mind and Medical Sciences 7, no. 2: 257-260. https://doi.org/10.22543/7674.72.P257260

APA Style

Onisâi, M. C., Iordan, I., Gaman, M., Bumbea, H., & Vlădăreanu, A.-M. (2020). Unexpected Hope for a Multiple Myeloma Patient. Journal of Mind and Medical Sciences, 7(2), 257-260. https://doi.org/10.22543/7674.72.P257260

Article Metrics

Back to TopTop